Stericycle (NASDAQ:SRCL) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCLFree Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the business services provider’s stock.

A number of other research analysts also recently commented on the company. Keefe, Bruyette & Woods boosted their target price on Stericycle from $135.00 to $142.00 and gave the company an outperform rating in a research note on Tuesday, June 4th. Royal Bank of Canada reissued a sector perform rating and set a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Robert W. Baird cut their price objective on Stericycle from $62.00 to $55.00 and set a neutral rating for the company in a research report on Friday, April 26th. Finally, Truist Financial upped their price target on Stericycle from $50.00 to $62.00 and gave the company a hold rating in a report on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of Hold and a consensus price target of $74.00.

View Our Latest Analysis on Stericycle

Stericycle Stock Performance

Shares of SRCL stock opened at $58.40 on Tuesday. Stericycle has a 1-year low of $37.78 and a 1-year high of $59.45. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $5.42 billion, a price-to-earnings ratio of -265.45, a P/E/G ratio of 3.16 and a beta of 1.11. The stock’s fifty day simple moving average is $56.12 and its 200-day simple moving average is $51.95.

Stericycle (NASDAQ:SRCLGet Free Report) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The business’s quarterly revenue was down 2.8% compared to the same quarter last year. On average, sell-side analysts predict that Stericycle will post 2.32 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Capital Research Global Investors raised its stake in Stericycle by 13.4% during the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after buying an additional 705,586 shares during the period. First Eagle Investment Management LLC raised its stake in Stericycle by 5.2% during the 1st quarter. First Eagle Investment Management LLC now owns 242,975 shares of the business services provider’s stock worth $12,817,000 after buying an additional 12,000 shares during the period. Robeco Institutional Asset Management B.V. bought a new position in Stericycle during the 4th quarter worth about $156,000. Illinois Municipal Retirement Fund bought a new position in Stericycle during the 1st quarter worth about $756,000. Finally, Sei Investments Co. increased its holdings in Stericycle by 5.9% during the 1st quarter. Sei Investments Co. now owns 1,124,481 shares of the business services provider’s stock worth $59,316,000 after purchasing an additional 63,112 shares in the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

About Stericycle

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Featured Stories

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.